Allarity Therapeutics, Inc. (ALLR)

USD 0.97

(-11.81%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - 120 Thousand
Cost of Revenue 37 Thousand 120 Thousand 106 Thousand 86 Thousand -
Gross Profit -37 Thousand -120 Thousand -106 Thousand -86 Thousand 120 Thousand
Operating Expenses 17.89 Million 16.89 Million 26.55 Million 9.22 Million 10.23 Million
Selling, General and Administrative Expenses 10.02 Million 9.96 Million 12.36 Million 4.1 Million 3.87 Million
Research and Development Expenses 7.86 Million 6.93 Million 14.19 Million 5.12 Million 6.36 Million
Other Expenses - - -474 Thousand -681 Thousand -
Cost and Expenses 17.92 Million 16.89 Million 26.55 Million 9.22 Million 10.23 Million
Operating Income -17.92 Million -34.46 Million -26.55 Million -9.22 Million -17.61 Million
Interest Expense 498 Thousand 223 Thousand 499 Thousand 227 Thousand 3.31 Million
Income Tax Expense -717 Thousand -1.52 Million 133 Thousand -2.16 Million -4.57 Million
Earnings before Tax -12.61 Million -17.57 Million -26.51 Million -7.23 Million -18.97 Million
Net Income -11.9 Million -16.05 Million -26.64 Million -5.07 Million -14.4 Million
Earnings Per Share Basic -0.01 -1.85 Million -3.52 Million -1.69 Million -189.61 Thousand
Earnings Per Share Diluted -0.01 -1.85 Million -3.52 Million -1.69 Million -189.61 Thousand
Weighted Average Shares Outstanding 1.99 Billion 11.34 7.57 3.89 3.89
Weighted Average Shares Outstanding (Diluted) 1.99 Billion 11.34 7.57 3.89 3.89
Gross Margin - - - - 1.00
EBIT Margin - - - - -83.82
Profit Margin - - - - -120.00
EBITDA -12.08 Million -17.23 Million -25.91 Million -6.01 Million -15.58 Million
Earnings Before Tax Margin - - - - -146.76

Income Statement Charts